Literature DB >> 1357403

Endogenous benzodiazepine receptor ligands in idiopathic recurring stupor.

J D Rothstein1, A Guidotti, P Tinuper, P Cortelli, P Avoni, G Plazzi, E Lugaresi, P Schoch, P Montagna.   

Abstract

"Endozepines" are endogenous ligands for the benzodiazepine recognition sites on gamma-aminobutyric acid A receptors in the nervous system. Idiopathic recurring stupor (IRS) is a syndrome of spontaneous stupor or coma that is not associated with known metabolic, toxic, or structural abnormalities but can be reversed by flumazenil, a pure benzodiazepine antagonist. We measured endozepine-2 and endozepine-4 by high-performance liquid chromatography and radioreceptor assay in serum and cerebrospinal fluid from three patients with IRS. During episodes of stupor there was a large (up to 300-fold compared with control patients) increase of endozepine-4 content in cerebrospinal fluid and serum, but a return to normal concentrations between attacks. Endozepine-4 may contribute to, or be the cause of, IRS. The reasons for abnormal concentrations of endozepine in blood and brain are unknown.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357403     DOI: 10.1016/0140-6736(92)93011-b

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

1.  Rigor, reproducibility, and in vitro cerebrospinal fluid assays: The devil in the details.

Authors:  Olivia A Moody; Sahil Talwar; Meagan A Jenkins; Amanda A Freeman; Lynn Marie Trotti; Paul S García; Donald Bliwise; Joseph W Lynch; Brad Cherson; Eric M Hernandez; Neil Feldman; Prabhjyot Saini; David B Rye; Andrew Jenkins
Journal:  Ann Neurol       Date:  2017-06-01       Impact factor: 10.422

2.  Endozepine-4 levels are increased in hepatic coma.

Authors:  Giulia Malaguarnera; Marco Vacante; Filippo Drago; Gaetano Bertino; Massimo Motta; Maria Giordano; Michele Malaguarnera
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

3.  Idiopathic recurrent stupor: Munchausen by proxy and medical litigation.

Authors:  Giuseppe Plazzi; David Rye; Luca Vignatelli; Roberto Riva; Elio Lugaresi
Journal:  Sleep       Date:  2014-01-01       Impact factor: 5.849

4.  Segmental Hair Testing of Triazolam to Unmask a Suspected Case of Idiopathic Recurrent Stupor.

Authors:  Emanuela Postiglione; Elena Antelmi; Monica Moresco; Simona Pichini; Fabio Pizza; Giuseppe Plazzi; Francesco Paolo Busardò
Journal:  J Clin Sleep Med       Date:  2018-04-15       Impact factor: 4.062

Review 5.  Endogenous benzodiazepine site peptide ligands operating bidirectionally in vivo in neurogenesis and thalamic oscillations.

Authors:  Hanns Möhler
Journal:  Neurochem Res       Date:  2014-04-09       Impact factor: 3.996

6.  Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gamma-aminobutyric acid type A receptors.

Authors:  U Günther; J Benson; D Benke; J M Fritschy; G Reyes; F Knoflach; F Crestani; A Aguzzi; M Arigoni; Y Lang; H Bluethmann; H Mohler; B Lüscher
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

7.  Reversal of triazolam- and zolpidem-induced memory impairment by flumazenil.

Authors:  N J Wesensten; T J Balkin; H Q Davis; G L Belenky
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

8.  Pharmacological plasticity of GABA(A) receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy.

Authors:  Claire Leroy; Pierrick Poisbeau; A Florence Keller; Astrid Nehlig
Journal:  J Physiol       Date:  2004-03-19       Impact factor: 5.182

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.